Agile Therapeutics
AGRX
$0.38
Share price
2.43%
Change (1 day)
-89.48%
Change (1 year)
Categories
Agile Therapeutics (AGRX) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $22.93 M
According to Agile Therapeutics 's latest financial reports the company's total liabilities are $22.93 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Agile Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $19.78 M | -44.13% |
| 2021-12-31 | $35.41 M | 49.23% |
| 2020-12-31 | $23.73 M | 525.4% |
| 2019-12-31 | $3.79 M | 71.1% |
| 2018-12-31 | $2.21 M | -84.46% |
| 2017-12-31 | $14.27 M | -33.86% |
| 2016-12-31 | $21.57 M | 4.35% |
| 2015-12-31 | $20.67 M | 9.87% |
| 2014-12-31 | $18.82 M | -78.08% |
| 2013-12-31 | $85.84 M | -0.32% |
| 2012-12-31 | $86.12 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $101.94 B | 444,419.05% | 🇺🇸 USA |
 Pfizer PFE | $128.53 B | 560,364.81% | 🇺🇸 USA |
 Merck MRK | $65.42 B | 285,175.14% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $13.42 M | -41.47% | 🇺🇸 USA |